SCHEMBL6783065

SCHEMBL6783065

OCC1CCCCC(O)(O)C1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.36
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3398441 0.77 APLNR (0.36) APLNR
SCHEMBL10285449 0.75 APLNR (0.31) APLNR
SCHEMBL3400842 0.74 APLNR (0.37) APLNR
SCHEMBL28566656 0.73 POLB (0.33)
SCHEMBL3397324 0.73 APLNR (0.36) APLNR
SCHEMBL17511761 0.73 ESR2 (0.32) APLNR
SCHEMBL5625 0.71
SCHEMBL3398771 0.70 APLNR (0.37) APLNR
SCHEMBL13646378 0.68 ESR1 (0.40) APLNR
SCHEMBL738125 0.68 ESR1 (0.40) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673920-B2 REACTING AMIDES WITH ACETYLENES IN THE LIQUID PHASE IN THE PRESENCE OF BASIC ALKALI METAL COMPOUNDS AND OF A COCATALYST, WHICH COMPRISES USING AS THE COCATALYST DIOLS TO PREPARE N-ALKENYL-AMIDE BASF AKTIENGESELLSCHAFT (DE) 2004-01-06 US disclosed
US-20030036659-A1 Method for the production of n-alkenyl amides BASF AKTIENGESELLSCHAFT (DE) 2003-02-20 US disclosed
EP-1240140-A1 METHOD FOR THE PRODUCTION OF N-ALKENYL AMIDES BASF AKTIENGESELLSCHAFT (DE) 2002-09-18 EP disclosed
WO-2001046141-A1 METHOD FOR THE PRODUCTION OF N-ALKENYL AMIDES BASF AKTIENGESELLSCHAFT (DE) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036659-A1 Method for the production of n-alkenyl amides NAT1, SAT1, AGPAT2 APLNR 1911/4885MGAM 1529/4885SI 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.